Metrics as of 10/15/2026, 04:21 PM (Berlin time), refresh in progress.
Carlsmed Stock
Carlsmed, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Michael Cordonnier
- Employees
- 127
- Market cap
- $366 M
- IPO
- 23/07/2025
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software,…
Carlsmed stock: price history
1D
-3.9%
1W
-7.0%
1M
-12.4%
6M
+22.1%
YTD
+8.6%
1Y
-1.6%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~18% stronger price swings than usual
Ask the agents about Carlsmed
Analyst assessment of Carlsmed
PRICE TARGET LOW
US$17.00
CONSENSUS
US$18.50
MEDIAN
US$18.50
PRICE TARGET HIGH
US$20.00
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 12/10/2026
Carlsmed stock metrics
P/E
-9.86
P/B
4.33
EV/EBITDA
-14.19
RETURN ON EQUITY
-12.5%
NET MARGIN
-55.5%
DEBT/EQUITY
0.26
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
37.4%
FLOAT SHARES
10,214,666
AVG. DAILY VOLUME (30D)
76,117
Insider transactions (SEC)
Bertolini Jeffrey
Bertolini Jeffrey
Bertolini Jeffrey
Bertolini Jeffrey
Heppenstall Richard
Institutional holders
Comparable stocks
Frequently asked questions about Carlsmed stock
What does Carlsmed do?
Carlsmed, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Michael Cordonnier, the company employs around 127 people.
The IPO was on 23/07/2025; the stock trades on NASDAQ under the ticker CARL.
What do analysts say about Carlsmed stock?
3 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$18.50, ranging from US$17.00 to US$20.00, with a median of US$18.50.
This is an external assessment, not a statement by Market Jury.
When does Carlsmed report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 18% stronger than usual.
Does Carlsmed pay a dividend?
No, Carlsmed currently does not pay a dividend.
Which stocks are comparable to Carlsmed?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Carlsmed stock analyzed?
Clicking "Analyze stock" lets five strategies assess Carlsmed against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.